publication venue for
- The class I HDAC inhibitor Romidepsin targets inflammatory breast cancer tumor emboli and synergizes with paclitaxel to inhibit metastasis.. 10. 2013
- Intra-arterial bevacizumab with blood brain barrier disruption in a glioblastoma xenograft model.. 10. 2012
- Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma.. 10. 2012
- Interstitial infusion of erlotinib in the rodent brain.. 8. 2009
- Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.. 7. 2008
- EGFR inhibitor-mediated apoptosis in solid tumors. 2007